US7163821066 - Common Stock
NASDAQ:PETS (2/6/2023, 12:40:04 PM)-1.07 (-4.85%)
|GICS Sector||Consumer Discretionary|
|GICS Industry||Internet & Direct Marketing Retail|
|Earnings (Last)||N/A N/A||Earnings (Next)||05-08 2023-05-08/amc|
|Ins Owners||0.82%||Inst Owners||79.02%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS INC
420 South Congress Avenue
Delray Beach FLORIDA 33445
CEO: Menderes Akdag
DELRAY BEACH, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the “Company”), Your Trusted Pet Health Expert™ will hold a conference...
PetMed Express (PETS) has agreed to acquire PetCareRx, a supplier of pet medications, food, and supplies.The transaction is set to close in Q1/2023
The Acquisition Is Expected to Accelerate Revenue Growth and Expand Addressable Market in a $120 Billion* U.S. Industry...
Here you can normally see the latest stock twits on PETS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.